Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene

Oncogene

Volumn 13, Issue 5, 1996, Pages 1083-1092

  Sánchez Prieto, Ricardo ^a   Quintanilla, Miguel ^b   Cano, Amparo ^b   Lleonart, Matilde ^a   Martin, Pilar ^a   Anaya, Alberto ^a   Ramón Y Cajal, Santiago ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Adenovirus E1a; Apoptosis; Carcinoma cell lines; Drug resistance; p53

Indexed keywords

CISPLATIN; CRYSTAL VIOLET; DOXORUBICIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOMA CELL; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DRUG POTENTIATION; FLOW CYTOMETRY; GAMMA IRRADIATION; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL; TUMOR SUPPRESSOR GENE; VIRUS GENE;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CISPLATIN; DNA DAMAGE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GAMMA RAYS; HELA CELLS; HUMANS; MICE; MUTATION; RADIATION-SENSITIZING AGENTS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029766528     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Ames RS, Holskin B, Mitcho M, Shalloway D and Chen M. (1990). J. Virol., 164, 4115-4122.
2. Arany Z, Sellers WR, Livingston DM and Eckner R. (1994). Cell, 77, 799-800.
3. Bayley ST and Mymryk JS. (1994). Int. J. Oncol., 5, 425-444.
4. Barbeau D, Charbonneau R, Whalen SG, Bayley ST and Branton PE. (1994). Oncogene, 9, 359-373.
5. Bishop JM. (1991). Cell, 64, 235-248.
6. Bouffler SD, Kemp CJ, Ballmain A and Cox R. (1995). Cancer Res., 55, 3883-3889.
7. Boulanger PA and Blair GE. (1991). J. Biochem., 275, 281-299.
8. Braitwaite A, Nelson C, Skulimowski A, McGovern J, Pigott D and Jenkins J. (1990). Virology, 177, 595-605.
9. Brown K, Quintanilla M, Ramiden M, Kerr IB, Young S and Balmain A. (1986). Cell, 46, 447-456.
10. Burns PA, Kemp CJ, Gannon JV, Lana AP, Bremmer R and Balmain A. (1991). Oncogene, 6, 2363-2369.
11. Caelles C, Helmberg A and Karin M. (1994). Nature, 370, 220-222.
12. Caruso M, Martelli F, Giordano A and Felsani A. (1993). Oncogene, 8, 267-278.
13. Chang F, Syrjänen and Syrjänen K. (1995). J. Clin. Oncol., 13, 1009-1022.
14. Chiou SK, Tseng CC, Rao L and White E. (1994a). J. of Virol., 68, 6553-6566.
15. Chiou SK, Rao L and White E. (1994b). Mol. Cell Biol., 14, 2556-2563.
16. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie H. (1993). Nature, 362, 849-852.
17. Cordon-Cardo C. (1995). Am. J. Pathol., 147, 545-560.
18. Debbas M and White E. (1993). Genes & Development, 7, 546-554.
19. Dotto GP, Moellman G, Ghosh S. Edwards M and Halaban R. (1989). J. Cell Biol., 109, 3115-3128.
20. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
21. Fisher DA. (1994). Cell, 78, 539-542.
22. Frisch SM, Reich R, Collier IE, Genrich T, Martin G and Goldberg GI. (1990). Oncogene, 5, 75-83.
23. Frisch SM. (1991). Proc. Natl. Acad. Sci. USA, 88, 9077-9081.
24. Frisch SM and Dolter KE. (1995). Cancer Res., 55, 5551-5555.
25. Fritsche M, Haessler C and Brandner G. (1993). Oncogene, 8, 307-318.
26. Furihata M, Sonobe H and Ohtsuki Y. (1995). Int. J. Oncol., 6, 1209-1226.
27. Gillies RJ, Didier N and Denton M. (1986). Analytical Biochemistry, 159, 109-113.
28. Harris CC and Holstein M. (1993). New Engl. J. Med., 329, 1318-1327.
29. Havre PA, Yuan J, Hedrick L, Cho KR and Glazer PM. (1995). Cancer Res., 55, 4420-4424.
30. Howe JA and Bayley ST. (1992). Virology, 186, 15-24.
31. Hunter T and Pines J. (1994). Cell, 79, 547-550.
32. Jayaraman L and Prives C. (1995). Cell, 81, 1021-1029.
33. Kasid U, Pfeifer A, Brennan T. Beckett M, Weichselbaum RR, Dritschilo and Mark GE. (1989). Science, 243, 1354-1356.
34. Kastan MB, Onyiekwere O, Sidransky D, Vogelstein B and Graig RW. (1991). Cancer Res., 51, 6304-6311.
35. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS Han SM, Lorincz AT, Hedrick L and Cho RK. (1993). Proc. Natl. Acad. Sci. USA, 90, 3988-3992.
36. Kuerbitz SJ, Plumkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
37. Lane DP. (1992). Nature, 358, 15-16.
38. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993a). Nature, 362, 847-849.
39. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993b). Cell, 74, 957-967.
40. Lowe SW and Ruley HE. (1993). Genes and Development, 7, 535-545.
41. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T. (1994). Science, 266, 807-810.
42. Lu X and Lane DP. (1993). Cell, 75, 765-778.
43. Marchetti E, Romero J, Sanchez R, Vargas JA, Lacal JC and Ramón y Cajal S. (1994). Int. J. Oncol., 5, 611-618.
44. Missero C, Ramon y Cajal S, Dotto GP. (1991). Proc. Natl. Acad. Sci. USA, 88, 1295-1300.
45. Mymrick JS, Shire K and Bayley ST. (1994). Oncogene, 9, 1187-1193.
46. Nelson WG and Kastan MB. (1994). Mol. Cell. Biol., 14, 1815-1823.
47. Paules RS, Levedakou EN, Wilson SJ, Innes CL, Rhodes N, Tlsty TD, Galloway DA, Donehower LA, Tainsky MA and Kaufmann WK. (1995). Cancer Res., 55, 1763-173.
48. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P and Massague J. (1994). Cell, 78, 59-66.
49. Ramón y Cajal S, Suster S, Halaban R, Filvaroff E and Dotto GP. (1991). Am. J. Pathol., 138, 349-358.
50. Ramón y Cajal S, Ricardo Sánches-Prieto and Anaya A. (1995). Histol. Histopathol., 10, 811-820.
51. Ramón y Cajal S, Marchetti E, Missero C and Dotto GP. (1994). Am. J. Pathol., 145, 846-855.
52. Sánchez-Prieto R, Vargas JA, Carnero A, Marchetti E, Romero J, Durantez A, Lacal JC and Ramón y Cajal S. (1995a). Int. J. Cancer, 60, 235-243.
53. Sánchez-Prieto R, Lleonart M and Ramón y Cajal S. (1995b). Oncogene, 11, 675-682.
54. Sânchez-Prieto R, Vargas JA, Durantez A, Anaya A and Ramón y Cajal S. (1995c). Oncology Reports, 2, 457-459.
55. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
56. Sklar MD. (1988). Science, 239, 645-649.
57. Slichemeyer WJ, Nelson WG, Slebos RJ and Kastan MB. (1993). Cancer Res., 53, 4164-4168.
58. Spindler KR and Berk AJ. (1984). J. Virol., 52, 706-710.
59. Strasser A, Harris AW, Jacks T and Cory S. (1994). Cell, 79, 329-339.
60. Tatsuka M, Nikaido O, Tatsumi K and Takebe H. (1989). Mutat. Res., 214, 321-328.
61. Teodoro JG, Shore GC and Branton PE. (1995). Oncogene, 11, 467-474.
62. Thompson CB. (1995). Science, 267, 1456-1462.
63. White P, Williamson NM and Harlow E. (1989). Cell, 45, 67-75.
64. White E and Stillman B. (1987). J. Virol., 61, 426-435.
65. Williams GT and Smith CA. (1993). Cell, 74, 777-779.
66. Wu X and Levine AJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 3602-3606.
67. Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence J-J, May P and Oren M. (1993). Mol. Cell Biol., 90, 1415-1423.
68. Zhang Y, Yu D, Xia W and Hung MC. (1995). Oncogene, 10, 1947-1954.